CVKD   $17.26  5.89% Market Closed After Close 17.5 1.39%

Cadrenal Therapeutics Inc
Total Cash 5.04M
totalCashPerShare 4.72
EBITDA -6.63M
Total Debt 8.80K
quickRatio 3.439
currentRatio 3.716
Total Revenue
debtToEquity 0.22
Revenue/Share
ROA -0.91899
ROE -1.74013
grossProfits
freeCashflow -2.54M
operatingCashflow -4.69M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 11.35M
forwardPE -3.2521188
floatShares 502.25K
sharesOutstanding 1.18M
sharesShort 18.03K
sharesShortPriorMonth 15.82K
dateShortInterest
sharesPercentSharesOut 0.02%
heldPercentInsiders 0.53%
heldPercentInstitutions 0.02%
Short Ratio help_outline 0.43%
shortPercentOfFloat 0.03%
impliedSharesOutstanding
bookValue 3.741
Price To Book help_outline 4.10
earningsQuarterlyGrowth
netIncomeToCommon -6.24M
trailingEps -4.80%
forwardEps -4.72%
enterpriseToEbitda -1.71
lastDividendValue
lastDividendDate
currentQuarterEstimate -1.93 3Q 2024
institutionsCount 10
lastUpdated Oct. 17, 2024, 10:10 a.m.